Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,059 | 19,486 | 8,232 | 20,897 | 24,237 |
| Receivables | 1,240 | 237 | 368 | 413 | 2,098 |
| Other current assets | 1,986 | 1,967 | 1,973 | 1,537 | 0 |
| TOTAL | $11,626 | $24,390 | $12,755 | $25,837 | $28,347 |
| Non-Current Assets | |||||
| PPE Net | 730 | 1,357 | 1,258 | 1,006 | 1,271 |
| Investments And Advances | 0 | 0 | 0 | 9 | 960 |
| Intangibles | 17 | 22 | 27 | 32 | 38 |
| Other Non-Current Assets | 2,322 | 1,027 | 1,077 | 1,083 | 995 |
| TOTAL | $3,069 | $2,406 | $2,362 | $2,130 | $3,264 |
| Total Assets | $14,695 | $26,796 | $15,117 | $27,967 | $31,611 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,308 | 5,240 | 1,886 | 1,755 | 2,331 |
| Accrued Expenses | 9,564 | 6,464 | 1,330 | 2,974 | 2,944 |
| Other current liabilities | 15 | 110 | 37 | N/A | N/A |
| TOTAL | $36,898 | $33,348 | $22,440 | $19,331 | $5,297 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 5,282 | 276 | N/A | N/A |
| Deferred Revenues | 20,173 | 20,838 | 18,748 | 14,602 | 22 |
| aiOther Non-Current Liabilities | 1,292 | 363 | 228 | 0 | 0 |
| TOTAL | $2,029 | $6,558 | $1,358 | $5,000 | $N/A |
| Total Liabilities | $38,927 | $39,906 | $23,798 | $24,331 | $5,297 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,078 | 17,702 | 11,228 | 8,920 | 8,107 |
| Common Shares | 3 | 2 | 1 | 1 | 1 |
| Retained earnings | -195,666 | -165,295 | -123,102 | -100,769 | -71,088 |
| Other shareholders' equity | 5,051 | 0 | 0 | 0 | 0 |
| TOTAL | $-24,232 | $-13,110 | $-8,681 | $3,636 | $26,314 |
| Total Liabilities And Equity | $14,695 | $26,796 | $15,117 | $27,967 | $31,611 |